Understanding how maternal antibodies help protect newborns from allergies
Mechanism and function of transplacental IgD
This study is looking at how a special antibody called IgD helps protect newborns from allergies, especially food allergies, by being passed from mothers to their babies during pregnancy, and it aims to find ways to boost babies' immune systems for better health.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Wayne State University NIH-funded |
| Lab location | 1 site (Detroit, United States) |
| Project ID | NIH-10861768 on NIH RePORTER |
What this research studies
This research investigates the role of a specific antibody, IgD, in protecting newborns from allergies, particularly food allergies. It focuses on how IgD is transferred from mothers to their babies during pregnancy and how it can enhance the immune system of infants. By studying the mechanisms of this transfer and the effects of maternal vaccination and food exposure, the research aims to identify ways to improve the health of neonates and reduce the incidence of allergies. The approach includes both laboratory studies and potential clinical applications to strengthen neonatal immunity.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include pregnant women and their newborns, particularly those at risk for developing food allergies.
Not a fit: Patients who are adults without children or those who do not have a history of allergies may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing and treating food allergies in infants, improving their overall health and quality of life.
How similar studies have performed: Previous research has shown promising results in understanding the role of maternal antibodies in infant immunity, suggesting that this approach could lead to significant advancements in allergy prevention.
Where this research is happening
Detroit, United States
- Wayne State University — Detroit, United States (Active)
Researchers
- Principal investigator: Chen, Kang — Wayne State University
- Study coordinator: Chen, Kang
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.